Serina Therapeutics SER
NYSE SER
$1.96 -0.03 (-1.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Serina Therapeutics (SER) Income from Discontinued Operations (2020 - 2021)

Updated

Serina Therapeutics (SER) reported Income from Discontinued Operations of -$103,000 for FY2021, compared with -$727,000 in FY2020.

Analysis

Serina Therapeutics (SER) Income from Discontinued Operations (2020 - 2021) Analysis & Trends

  • According to Business Quant data, Income from Discontinued Operations came in at -$727,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 8.00 Mn
10 Serina Therapeutics 32.11 Mn -8.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -103,000.00
Dec 31, 2020 -198,000.00
Sep 30, 2020 -41,000.00
Jun 30, 2020 -299,000.00
Mar 31, 2020 -189,000.00
API Access

Serina Therapeutics Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=SER&period=max&api_key=YOUR_API_KEY